Torrent Pharmaceuticals Ltd Share Price
(TORNTPHARM)
₹3087.4
as on 09:27AM, 21 Feb 2025
Torrent Pharmaceuticals Ltd Performance
Day's Low
Day's High
₹3,078.6Day's Price Range₹3,107.1552 Week's Low
52 Week's High
₹2,487.852-Week Price Range₹3,590.7
| Returns % | |
| 1 Month Return | -1.91 % |
| 3 Month Return | -0.19 % |
| 1 Year Return | + 18.94 % |
| Market Stats | |
| Previous Close | ₹3,095.95 |
| Open | ₹3,080.75 |
| Volume | 2.23L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹1,04,776.31Cr |
Torrent Pharmaceuticals Ltd Key Statistics
P/E Ratio
56.26
PEG Ratio
5.17
Market Cap
₹1,04,776.31 Cr
P/B Ratio
12.89
EPS
48.94
Dividend Yield
1.08
Sector
Pharmaceuticals
ROE
20.43
Torrent Pharmaceuticals Ltd Mutual Fund Holdings
Torrent Pharmaceuticals Ltd Analyst Rating
based on 29 analysts
63.33%
Buy
23.33%
Hold
13.33%
Sell
Based on 29 analysts offering long term price targets for Torrent Pharmaceuticals Ltd. An average target of ₹3639.83
Source: S&P Global Market Intelligence
Torrent Pharmaceuticals Ltd Share analysis
Torrent Pharmaceuticals Ltd price forecast by 29 analysts
Upside of17.57%
High
₹4232
Target
₹3639.83
Low
₹2930
Torrent Pharmaceuticals Ltd target price ₹3639.83, a slight upside of 17.57% compared to current price of ₹3087.4. According to 29 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Torrent Pharmaceuticals Ltd revenue growth forecast
Expected growth rate Q1, FY2027:37.14%
Forecast
Actual
Including amortisation and stock based compensations
Torrent Pharmaceuticals Ltd EPS growth forecast
EPS estimate Q1, FY2027:88.17%
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Torrent Pharmaceuticals Ltd
Torrent Pharma Fined for Input Tax Credit Issues - 17 Feb, 2025
Torrent Pharmaceuticals Ltd. has been penalized Rs 20.96 lakh for alleged excess input tax credit discrepancies. The company plans to appeal and expects minimal financial impact.Torrent Pharmaceuticals Continues Upward Trend - 07 Feb, 2025
Torrent Pharmaceuticals Ltd has risen for the third consecutive session, currently trading at Rs 3265.2, up 3.29%. The stock has gained 23.41% over the past year, outperforming both the NIFTY and Nifty Pharma index. Despite a recent 1.79% decline over the last month, trading volume is slightly above average today.Torrent Pharmaceuticals Faces Continued Decline - 04 Feb, 2025
Torrent Pharmaceuticals Ltd has declined for the fifth consecutive session, currently trading at Rs 3104.75, down 2.02%. The stock has eased 7.68% over the past month, underperforming the Nifty Pharma index, which has decreased by 5.88%. Despite a 17.44% increase over the last year, the stock's recent performance indicates a downward trend.Torrent Pharma Targets Higher Prices Amid Bullish Momentum - 29 Jan, 2025
Torrent Pharmaceuticals is experiencing strong bullish momentum, with targets of ₹3,750 and ₹3,800. The stock has shown impressive returns and increasing foreign institutional investment.Torrent Pharma Reports Growth Amid Challenges - 28 Jan, 2025
Torrent Pharma's December 2024 net sales rose 2.82% YoY, with net profit increasing 13.54%. Motilal Oswal adjusts EPS estimates, targeting ₹3,410.Torrent Pharmaceuticals Reports Strong Q3 Growth and Future Prospects - 27 Jan, 2025
Torrent Pharmaceuticals shows robust performance with a 13.5% profit increase in Q3 FY25, strong revenue growth, and positive future projections, including US market launches. The company also declared an interim dividend, reflecting solid financial health.Torrent Pharma Q3 Results Miss Estimates Despite Profit Rise - 24 Jan, 2025
Torrent Pharmaceuticals reported a 14% increase in Q3 net profit to Rs 503 crore, but fell short of analyst expectations due to an insulin facility closure and currency depreciation in Brazil.Torrent Pharmaceuticals Set to Announce Earnings - 23 Jan, 2025
Torrent Pharmaceuticals is scheduled to report its December quarter earnings on January 24, amidst a volatile global healthcare environment.Torrent Pharmaceuticals Excels in US Export Market - 21 Jan, 2025
Torrent Pharmaceuticals, along with other companies, is experiencing strong performance in exports, particularly driven by success in the US market.
Insights on Torrent Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, TORNTPHARM stock has moved up by 1.5%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 453.0 Cr → 503.0 Cr (in ₹), with an average increase of 9.9% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 14.46% to 16.17% in Dec 2024 quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, TORNTPHARM has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 3.69% to 4.88% in Dec 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 59.9% return, outperforming this stock by 41.9%
NEGATIVE IMPACTPromoter Holding Down
Promoters have decreased holdings from 71.25% to 68.31% in Dec 2024 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 7.21% to 7.17% in Dec 2024 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 2.88K Cr → 2.84K Cr (in ₹), with an average decrease of 0.7% per quarter
Torrent Pharmaceuticals Ltd Financials
Index Inclusions
Torrent Pharmaceuticals Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 68.31% | ||
| Foreign Institutions | 16.17% | 11.84 | |
| Mutual Funds | 4.88% | 32.33 | |
| Retail Investors | 7.17% | ||
| Others | 3.47% | 2.19 |
Torrent Pharmaceuticals Ltd Key Indicators
Torrent Pharmaceuticals Ltd Valuation
Torrent Pharmaceuticals Ltd in the last 5 years
Lowest (31.60x)
April 2, 2018
Industry (51.76x)
February 20, 2025
Today (56.26x)
February 20, 2025
Highest (73.85x)
April 3, 2019
Torrent Pharmaceuticals Ltd Earnings and Dividends
Torrent Pharmaceuticals Ltd Earnings Results
Torrent Pharmaceuticals Ltd’s net profit jumped 13.54% since last year same period to ₹503Cr in the Q3 2024-2025. On a quarterly growth basis, Torrent Pharmaceuticals Ltd has generated 11.04% jump in its net profits since last 3-months.
Read More about Earnings ResultsTorrent Pharmaceuticals Ltd Dividends January,2025
In the quarter ending December 2024, Torrent Pharmaceuticals Ltd has declared dividend of ₹26 - translating a dividend yield of 1.74%.
Read More about Dividends
Torrent Pharmaceuticals Ltd Technicals Summary
Bearish
Neutral
Bullish
Torrent Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
Torrent Pharmaceuticals Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹1,04,776.31 Cr | 37.04% | 0.67 | ₹1,656 Cr | ₹10,727 Cr | |
| HOLD | ₹1,58,705.08 Cr | 35.34% | 0.50 | ₹1,600 Cr | ₹7,845 Cr | |
| BUY | ₹40,340.16 Cr | 1.38% | 0.58 | ₹1,297 Cr | ₹14,755 Cr | |
| HOLD | ₹25,041.44 Cr | -3.29% | 0.50 | ₹772 Cr | ₹5,664 Cr | |
| BUY | ₹1,19,502.65 Cr | 48.8% | 0.50 | ₹4,155 Cr | ₹25,774 Cr |
About Torrent Pharmaceuticals Ltd
The company is focused on producing high-quality, affordable medicines for the treatment of a wide range of diseases. Its top products include cardiovascular drugs, antibiotics, anti-diabetic drugs, anti-inflammatory drugs, and anti-infective drugs. Popular brands include Cadila, Torleva, Torlip, and Torleva XR.
Share Price: ₹3087.40 per share as on 21 Feb, 2025 09:27 AM
Market Capitalisation: ₹1,04,776.31Cr as of today
Revenue: ₹2,762.00Cr as on December 2024 (Q4 24)
Net Profit: ₹503.00Cr as on December 2024 (Q4 24)
Listing date: 03 Nov, 1994
Chairperson Name: Sudhir Mehta
| Organisation | Torrent Pharmaceuticals Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Torrent Pharmaceuticals Ltd
What is Torrent Pharmaceuticals Ltd price today?
Torrent Pharmaceuticals Ltd share price today stands at ₹3087.4, Open: ₹3080.75, Previous Close: ₹3095.95, High: ₹3107.15, Low: ₹3078.6, 52 Week High: ₹3590.7, 52 Week Low: ₹2487.8.
How to Buy Torrent Pharmaceuticals Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Torrent Pharmaceuticals Ltd shares
Is Torrent Pharmaceuticals Ltd listed on NSE?
Torrent Pharmaceuticals Ltd is listed on NSE
Is Torrent Pharmaceuticals Ltd listed on BSE?
Torrent Pharmaceuticals Ltd is listed on BSE
What are today's High and Low prices of Torrent Pharmaceuticals Ltd?
- Today's highest price of Torrent Pharmaceuticals Ltd is ₹3107.15.
- Today's lowest price of Torrent Pharmaceuticals Ltd is ₹3078.6.
What are today's traded volumes of Torrent Pharmaceuticals Ltd?
Today's traded volume of Torrent Pharmaceuticals Ltd(TORNTPHARM) is 2.23L.
What is today's market capitalisation of Torrent Pharmaceuticals Ltd?
Today's market capitalisation of Torrent Pharmaceuticals Ltd(TORNTPHARM) is ₹104776.31Cr.
What is the 52 Week High and Low Range of Torrent Pharmaceuticals Ltd?
How much percentage Torrent Pharmaceuticals Ltd is down from its 52 Week High?
Torrent Pharmaceuticals Ltd (TORNTPHARM) share price is ₹3087.4. It is down -14.02% from its 52 Week High price of ₹3590.7
How much percentage Torrent Pharmaceuticals Ltd is up from its 52 Week low?
Torrent Pharmaceuticals Ltd (TORNTPHARM) share price is ₹3087.4. It is up 24.10% from its 52 Week Low price of ₹2487.8
What are the historical returns of Torrent Pharmaceuticals Ltd?
What is the PE ratio of Torrent Pharmaceuticals Ltd today?
PE Ratio of Torrent Pharmaceuticals Ltd is 56.26
PE ratio = Torrent Pharmaceuticals Ltd Market price per share / Torrent Pharmaceuticals Ltd Earnings per share